Skip to content

Applied Therapeutics Inc Sustainability Reports

Applied Therapeutics, Inc. is a biopharmaceutical company focusing on developing a pipeline of novel drug candidates against validated molecular targets in rare diseases. The company's pipeline includes treatments for classic galactosemia, SORD deficiency, and diabetic complications.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: 549300KL3IJPHZM2GR04

FIGI: BBG001SMJMY2

3 reports from 2019 to 2024